Table 3.
Deposition fractions (as a percentage of aerosolized dose) based on CFD predictions compared with the in vivo data of Newman et al. (51) (in parentheses) for the Novolizer operated with a QD waveform and PIFR of 99 LPM.
| MP+MT | 67 (66.5) |
| Central lung (trachea excluded) | 9.0 (10.6) |
| Intermediate and peripheral lung | 22.1 (19.4) |
| Trachea-B3 | 2.7 |
| B4-B7 | 8.2 |
| B8-B15 | 1.8 |
| Alveolar | 20.3 |